Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT04906421

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

This is a Phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy on TVB-2640 in subjects with non-alcohol…

United States168 participantsStarted 2021-08-12

Treatment: TVB-2640, Placebo